Ittai Harel - Jun 1, 2022 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role
Director
Signature
/s/ Ittai Harel
Stock symbol
TCRX
Transactions as of
Jun 1, 2022
Transactions value $
$0
Form type
4
Date filed
6/3/2022, 04:30 PM
Previous filing
Jul 15, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRX Stock Option (Right to Buy) Award $0 +9.15K $0.00 9.15K Jun 1, 2022 Voting Common Stock 9.15K $3.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 1, 2023 and (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service at such time.